Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

454 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Time for a new obesity narrative.
Ralston J, Brinsden H, Buse K, Candeias V, Caterson I, Hassell T, Kumanyika S, Nece P, Nishtar S, Patton I, Proietto J, Salas XR, Reddy S, Ryan D, Sharma AM, Swinburn B, Wilding J, Woodward E. Ralston J, et al. Among authors: wilding j. Lancet. 2018 Oct 20;392(10156):1384-1386. doi: 10.1016/S0140-6736(18)32537-6. Epub 2018 Oct 10. Lancet. 2018. PMID: 30316458 No abstract available.
Modern management of obesity.
Aditya BS, Wilding JP. Aditya BS, et al. Clin Med (Lond). 2009 Dec;9(6):617-21; quiz 622-3. doi: 10.7861/clinmedicine.9-6-617. Clin Med (Lond). 2009. PMID: 20095314 Free PMC article. Review. No abstract available.
Management of obesity.
Bray GA, Frühbeck G, Ryan DH, Wilding JP. Bray GA, et al. Lancet. 2016 May 7;387(10031):1947-56. doi: 10.1016/S0140-6736(16)00271-3. Epub 2016 Feb 10. Lancet. 2016. PMID: 26868660 Free article. Review.
Weighing up dietary patterns - Authors' reply.
Bray GA, Frühbeck G, Ryan DH, Wilding JP. Bray GA, et al. Lancet. 2016 Aug 20;388(10046):759-60. doi: 10.1016/S0140-6736(16)31359-9. Lancet. 2016. PMID: 27560275 No abstract available.
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DCW, Van Gaal L, Ortiz RV, Wilding JPH, Skjøth TV, Manning LS, Pi-Sunyer X; SCALE Obesity Prediabetes NN8022-1839 Study Group. le Roux CW, et al. Lancet. 2017 Apr 8;389(10077):1399-1409. doi: 10.1016/S0140-6736(17)30069-7. Epub 2017 Feb 23. Lancet. 2017. PMID: 28237263 Free article. Clinical Trial.
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial.
O'Neil PM, Birkenfeld AL, McGowan B, Mosenzon O, Pedersen SD, Wharton S, Carson CG, Jepsen CH, Kabisch M, Wilding JPH. O'Neil PM, et al. Lancet. 2018 Aug 25;392(10148):637-649. doi: 10.1016/S0140-6736(18)31773-2. Epub 2018 Aug 16. Lancet. 2018. PMID: 30122305 Clinical Trial.
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Zelniker TA, Wiviott SD, Raz I, Im K, Goodrich EL, Bonaca MP, Mosenzon O, Kato ET, Cahn A, Furtado RHM, Bhatt DL, Leiter LA, McGuire DK, Wilding JPH, Sabatine MS. Zelniker TA, et al. Lancet. 2019 Jan 5;393(10166):31-39. doi: 10.1016/S0140-6736(18)32590-X. Epub 2018 Nov 10. Lancet. 2019. PMID: 30424892
Should obesity be recognised as a disease?
Wilding JPH, Mooney V, Pile R. Wilding JPH, et al. BMJ. 2019 Jul 17;366:l4258. doi: 10.1136/bmj.l4258. BMJ. 2019. PMID: 31315832 No abstract available.
454 results